Preclinical safety and efficacy evaluation of the Pipeline Vantage Embolization Device with Shield Technology

BACKGROUND: The Pipeline Vantage Embolization Device with Shield Technology is a next generation flow diverter developed to improve aneurysm occlusion and implant endothelialization in addition to lowering thrombogenicity. We report here the in vivo biocompatibility and in vitro hemocompatibility pe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Neurointerv Surg
Autores principales: Starke, Robert M, Thompson, John, Pagani, Ariana, Choubey, Animesh, Wainwright, John M, Wolf, Michael F, Jahanbekam, Reza, Girdhar, Gaurav
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2020
Materias:
New Devices and Techniques
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509525/
https://ncbi.nlm.nih.gov/pubmed/32487767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/neurintsurg-2020-016043
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares